Texas Medical Technology invests in Olive Diagnostics, the world’s first hands-free, toilet-mounted urinalysis device


By investing in Olive Diagnostics, Texas Medical Technology actively supports providing people with practical information about their own personal health

HOUSTON, February 01, 2022–(BUSINESS WIRE)–Texas Medical Technology, a leading manufacturer and distributor of medical supplies and equipment, announces a substantial investment in Olive Diagnostics, a medical technology company transforming urinalysis testing home with a passive and continuous home monitoring system mounted on a toilet. Olive’s KG device is a hands-free, non-invasive, artificial intelligence (AI)-based device that provides 24/7 remote diagnostics by detecting the molecular composition of urine.

Self-monitoring of one’s health plays a crucial role in our ability to prevent disease and improve health care. With new technologies and the digitization of healthcare, simple and quick home diagnostics can serve as a central vehicle for this, where regular self-monitoring of the user’s urine enables users to detect plethora early. potential problems including urinary tract infections, kidney stones, heart failure and dehydration.

Texas Medical Technology‘s investment in Olive Diagnostics will support the company’s mission to help individuals and businesses lead safer, healthier lifestyles. Olive’s KG device, mounted on any toilet, is the world’s first hands-free digital urinalysis tool. The company’s cloud-based AI system calculates concentrations of molecules in the user’s urine, using proprietary algorithms to analyze and track collected data, alerting the user to any changes or abnormalities.

The diagnostic tool combines the best of biochemical and spectroscopic research with the latest advances in biomedical sciences, AI and data analysis. Clinical trials at Hadassah Ein Kerem in Jerusalem, conducted and analyzed by a third-party Technostat, confirmed the ability of the Olive system to effectively detect protein in urine in over 900 samples, proving more effective than urine sticks traditional. The diagnostic tool is currently used by four assisted living facilities in Europe.

The partnership between Texas Medical Technology and Olive Diagnostics is part of a broader commitment to building MetaHealth, a Metaverse-like virtual platform that will ultimately enable decision makers to execute the needs of healthcare networks through a avatar. This metaverse for health will become essential in the future to change, improve and eventually transform health care.

Texas Medical Technology was created to meet the growing demand for personal protective equipment during the COVID-19 pandemic. The company now has a 144,000 square foot factory in Houston, Texas, which employs 550 workers from 53 countries, including refugees assisted by the YMCA of Greater Houston and the Catholic Charities of the Archdiocese of Galveston-Houston. True to its mission to help disadvantaged communities across the country, the company also recently announced joint ventures with The Modoc Nation of Oklahoma.

“Giving people actionable insight into their own personal health data will be a huge step forward for peace of mind today,” says Corey Katz, co-founder of Olive Diagnostics. “Most importantly, by using simple preventative and detective measures such as the KG device, we are able to improve the health of the population and begin to explore other opportunities such as predictive analytics with home diagnostics.

“We have been incredibly impressed with Olive’s abilities to optimize home diagnostic tools at a time when we need them most,” said Omri Shafran, founder and CEO of Texas Medical Technology. “Keeping people informed about their bodily functions on an ongoing basis will become a central part of healthcare systems in the future, and I’m confident that Olive Diagnostics will help lead this push with new technologies constantly being discovered.”

About Texas Medical Technology
Texas Medical Technology, one of the fastest growing companies in the United States, has taken supply challenges and put them on its shoulders by bringing attention to COVID-related PPE. Provide a range of state-of-the-art technological and non-technological equipment to enable administrators to monitor potential medical crises and protect employees. For more information, please visit https://texasmedicaltechnology.com/

About Olive Diagnostics
Jerusalem-based Olive Diagnostics was founded in 2019 by CEO Guy Goldman and Corey Katz, a California-based wellness physician. The company has developed a non-invasive passive urinalysis sensor that provides real-time health alerts, early detection and disease progression information. Using optics for data collection, the sensor is mounted inside the toilet and requires no further intervention. The sensor detects the composition of urine and sends the data to the cloud. AI algorithms then process the sample results with historical user data to detect trends. Results are returned to the user via a mobile app, and biomarker data is also sent directly to the electronic health record (EHR) system for physician and provider accessibility. For more information visit https://www.olive.earth/

See the source version on businesswire.com: https://www.businesswire.com/news/home/20220201006010/en/


Media Contact
Lea Berdugo
ReBlonde for Texas Medical Technology
[email protected]

Source link


Comments are closed.